Search Results

• • 61 

    Academic Journals

  • Sort by: sorttype.publication.date.desc Newest sorttype.publication.date.asc Oldest sorttype.relevance Relevance

• 15E Menopause and HRT

  From:MPR Obstetrician & Gynecologist Edition (Vol. 19, Issue 3) Peer-Reviewed

  Fall 20083,802 words Article 770LPRESCRIBING NOTES For osteoporosis see Section 12C. For calcium and vitamin D supplements see Section 14A. Hormone replacement therapy (HRT) is the most effective intervention for the management of quality-of-life...

• Trimegestone effective for flushing, bone loss

  From:Patient Care (Vol. 38, Issue 1) Peer-Reviewed

  Jan. 2004218 words Brief article Researchers reported on a study showing that combined sequential estrogen and trimegestone--a novel progestin--holds promise in treating postmenopausal vasomotor symptoms and vaginal atrophy as well as increasing bone...

• 11F Menopause and HRT

  From:MPR Obstetrician & Gynecologist Edition (Vol. 22, Issue 2) Peer-Reviewed

  Fall-Winter 20113,559 words Drug overview 750LPRESCRIBING NOTES For osteoporosis see Section 9C. For calcium and vitamin D supplements see Section 10A. Hormone replacement therapy (HRT) is the most effective intervention for the management of quality-of-life...

• 12E Menopause and HRT

  From:MPR Obstetrician & Gynecologist Edition (Vol. 20, Issue 2) Peer-Reviewed

  Summer 20093,843 words Drug overview 780LPRESCRIBING NOTES For osteoporosis see Section 9C. For calcium and vitamin D supplements see Section 11A. Hormone replacement therapy (HRT) is the most effective intervention for the management of...

• Divorcing estrogen's bright and dark sides. (Endocrinology)

  Author:Greg MillerFrom:Science (Vol. 298, Issue 5594) Peer-Reviewed

  Oct. 25, 2002639 words Article Despite concerns about the risks of hormone replacement therapy for postmenopausal women, one benefit has not been challenged: It makes bones stronger. Now a study on page 843 suggests that it might be possible to tease...

• Divigel

  From:Formulary (Vol. 42, Issue 7) Peer-Reviewed

  July 200718 words Brief article 1310LFDA has approved estradiol gel 0.1% (Divigel, Upsher-Smith) for the treatment of moderate-to-severe hot flashes associated with menopause....

• FDA to scrutinize efficacy of Estratest for hot flashes: manufacturer to defend the combo product. (Used Off Label for Sexual Dysfunction)

  Author:Kate JohnsonFrom:Family Practice News (Vol. 33, Issue 10)

  May 15, 2003686 words Product/service eval... The Food and Drug Administration has begun a formal process to evaluate the efficacy of two estrogen androgen combinations currently marketed for the treatment of moderate to severe menopausal hot flashes in women who...

• Transdermal progesterone ineffective for menopausal symptoms. (Patient Oriented Evidence That Matters: practice recommendations from key studies)

  Author:Deborah SturpeFrom:Journal of Family Practice (Vol. 52, Issue 5) Peer-Reviewed

  May 2003655 words Article Wren BG, Champion SM, Willetts K, Manga RZ, Eden JA. Transdermal progesterone and its effect on vasomotor symptoms, blood lipid levels, bone metabolic markers, moods, and quality of life for postmenopausal women....

• A first prospective, randomized, double-blind, placebo-controlled study on the use of a standardized hop extract to alleviate menopausal discomforts

  Authors:A. Heyerick, S. Vervarcke, and H. DepypereFrom:Alternative Medicine Review (Vol. 11, Issue 1) Peer-Reviewed

  Mar. 2006250 words Brief article 1360LOBJECTIVES: To examine the efficacy of a hop extract enriched in 8-prenylnaringenin (8-PN, the phytoestrogen in hops, Humulus lupulus L.) on relief of menopausal discomforts. METHODS: A prospective, randomized,...

• Hormone replacement therapy and acute MI: a tale of fibrinolytic ups and downs

  Authors:R.J. Katz, J. Hsia, and P. WalkerFrom:Consultant (Vol. 37, Issue 3) Peer-Reviewed

  Mar. 1997288 words Brief article Hormone replacement therapy protection on postmenopausal women against early morning spike during myocardial infarction and ischemic stroke was analyzed. Results of a study on women who received hormonal therapy of...

• Don't write off low-dose HT for bone health: low-dose HT should be considered to reduce fracture risk and menopausal symptoms in certain patients

  Author:Colin NelsonFrom:Family Practice News (Vol. 35, Issue 18)

  Sept. 15, 2005792 words Article DED HAM, MASS. -- Has the backlash against hormone therapy gone too far? Should doctors take yet another look at the evidence and find selective uses for HT that maximize its benefits and minimize its risks? The...

• FDA requests updated hormone therapy labeling: recent trial data

  Author:Diana MahoneyFrom:Family Practice News (Vol. 34, Issue 6)

  Mar. 15, 2004304 words Brief article Black box warnings on hormone therapy products prescribed for postmenopausal women should be updated to include data from a recent trial suggesting that combination therapy does not prevent mild cognitive impairment,...

• Determinants of willingness to pay for a new therapy in a sample of menopausal-aged women

  Authors:Andrej Rasch, Jan-Marc Hodek, Claus Runge, and Wolfgang GreinerFrom:PharmacoEconomics (Vol. 27, Issue 8) Peer-Reviewed

  Aug. 20096,340 words Report Background: Menopause is a natural physiological event that usually begins in women between the ages of 48 and 55 years. In many cases, this event is associated with unpleasant somatic-vegetative, urogenital or...

• 12F Menopause and HRT

  From:MPR Obstetrician & Gynecologist Edition (Vol. 21, Issue 2) Peer-Reviewed

  Fall-Winter 20103,670 words Drug overview 740LPRESCRIBING NOTES For osteoporosis see Section 9C. For calcium and vitamin D supplements see Section 11A. Hormone replacement therapy (HRT) is the most effective intervention for the management of quality-of-life...

• A new topical emulsion formulation of estradiol

  From:Formulary (Vol. 38, Issue 11) Peer-Reviewed

  Nov. 200324 words Brief article A new topical emulsion formulation of estradiol (Estrasorb, Novavax/King) was approved for short-term use to reduce moderate-to-severe vasomotor symptoms ("hot flashes") in menopausal women....

• Breast CA Risk Rises Slightly Among HRT Users

  Author:MAUREEN DONOHUEFrom:Family Practice News (Vol. 30, Issue 5)

  Mar. 1, 2000796 words Article Publication of a study indicating that long-term estrogen-progestin replacement therapy increases the risk of breast cancer in postmenopausal women has stirred up the long-standing controversy on breast cancer and HRT...

• 15E Menopause and HRT

  From:MPR Obstetrician & Gynecologist Edition (Vol. 19, Issue 2) Peer-Reviewed

  Summer 20083,639 words Drug overview 760LPRESCRIBING NOTES For osteoporosis see Section 12C. For calcium and vitamin D supplements see Section 14A. Hormone replacement therapy (HRT) is the most effective intervention for the management of quality-of-life...

• Tibolone (Organon)

  From:Formulary (Vol. 41, Issue 7) Peer-Reviewed

  July 20068 words Brief article Tibolone (Organon) for the treatment of menopausal symptoms...

• Chinese herb is estrogen-active

  From:Family Practice News (Vol. 33, Issue 17)

  Sept. 1, 2003173 words Brief article The ancient Chinese herb fo-ti has estradiol-like activity in laboratory tests, Dr. Karen Klein said in a poster presentation at the annual meeting of the Endocrine Society. This discovery adds fo-ti to the list of...

• Red clover not effective for menopause

  From:British Medical Journal (Vol. 327, Issue 7407) Peer-Reviewed

  July 19, 200347 words Brief article Red clover not effective for menopause: Two popular herbal remedies, Promensil and Rimostil, which contain phytoestrogens extracted from red clover, are no more effective than placebo for treating menopausal symptoms...